These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8142332)

  • 1. Absorption of iron from ferric hydroxypyranone complexes.
    Maxton DG; Thompson RP; Hider RC
    Br J Nutr; 1994 Feb; 71(2):203-7. PubMed ID: 8142332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test.
    Kelsey SM; Hider RC; Bloor JR; Blake DR; Gutteridge CN; Newland AC
    J Clin Pharm Ther; 1991 Apr; 16(2):117-22. PubMed ID: 1856249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is ferric ion absorbed? Absorption of ferrous and ferric ions in healthy subjects and anemic patients].
    Heyder N; Waldherr A; Hartwich G
    Fortschr Med; 1982 Jul; 100(26):1259-61. PubMed ID: 7118034
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat.
    Barrand MA; Callingham BA
    Br J Pharmacol; 1991 Feb; 102(2):408-14. PubMed ID: 2015422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of ferric maltol, a novel ferric iron compound, in iron-deficient subjects.
    Kelsey SM; Blake DR; Hider RC; Gutteridge CN; Newland AC
    Clin Lab Haematol; 1989; 11(3):287-8. PubMed ID: 2591161
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the absorption of divalent and trivalent iron in living rats.
    Schäfer S; Forth W
    Arzneimittelforschung; 1984; 34(11):1570-4. PubMed ID: 6543132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the absorption of iron from Fe(III)EDTA.
    MacPhail AP; Bothwell TH; Torrance JD; Derman DP; Bezwoda WR; Charlton RW; Mayet F
    Br J Nutr; 1981 Mar; 45(2):215-27. PubMed ID: 6260128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine.
    Barrand MA; Callingham BA; Hider RC
    J Pharm Pharmacol; 1987 Mar; 39(3):203-11. PubMed ID: 2883285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat.
    Barrand MA; Callingham BA; Dobbin P; Hider RC
    Br J Pharmacol; 1991 Mar; 102(3):723-9. PubMed ID: 1364845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
    Geisser P; Müller A
    Arzneimittelforschung; 1984; 34(11):1560-9. PubMed ID: 6543131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal absorption of iron in the anemic mouse.
    Kurahori T; Miyazaki H
    Radioisotopes; 1979 May; 28(5):313-5. PubMed ID: 472382
    [No Abstract]   [Full Text] [Related]  

  • 14. The importance of reductive mechanisms for intestinal uptake of iron from ferric maltol and ferric nitrilotriacetic acid (NTA).
    Barrand MA; Hider RC; Callingham BA
    J Pharm Pharmacol; 1990 Apr; 42(4):279-82. PubMed ID: 1974298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation effects of a novel iron compound, ferric maltol. A comparison with ferrous sulphate.
    Singh RK; Barrand MA
    J Pharm Pharmacol; 1990 Apr; 42(4):276-9. PubMed ID: 1974297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose.
    Jacobs P; Johnson G; Wood L
    J Med; 1984; 15(5-6):367-77. PubMed ID: 6599114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal absorption of 59Fe from neutron-activated commercial oral iron(III)-citrate and iron(III)-hydroxide-polymaltose complexes in man.
    Heinrich HC
    Arzneimittelforschung; 1987 Jan; 37(1A):105-7. PubMed ID: 3566863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Ferric Maltol Does Not Adversely Affect the Intestinal Microbiome of Patients or Mice, But Ferrous Sulphate Does.
    Mahalhal A; Frau A; Burkitt MD; Ijaz UZ; Lamb CA; Mansfield JC; Lewis S; Pritchard DM; Probert CS
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron.
    Harvey RS; Reffitt DM; Doig LA; Meenan J; Ellis RD; Thompson RP; Powell JJ
    Aliment Pharmacol Ther; 1998 Sep; 12(9):845-8. PubMed ID: 9768526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal uptake, mucosal transfer and retention of a therapeutic dose of iron.
    Marx JJ; Stiekema J
    Eur J Clin Pharmacol; 1982 Oct; 23(4):335-8. PubMed ID: 7173303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.